Price (90d)
$21.41Signal Score (90d)
80Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $2.82B | $71.35M | $0.10 |
| 2024 | $2.70B | $243.14M | $0.36 |
| 2023 | $2.18B | $306.01M | $0.56 |
| 2022 | $2.06B | $500.45M | $0.92 |
| 2021 | $1.90B | $505.54M | $0.93 |
Social Signal Score
Earnings
Thu, Oct 22(in 2 months)
Consensus estimate $0.05 per share
Typical surprise +4.4% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Aug 4$0.08 vs $0.03beat
- Tue, May 5$0.28 vs $0.05beat
- Mon, Feb 2$0.47 vs $0.45beat
- Thu, Oct 23$0.46 vs $0.45beat
- Thu, Jul 24$0.46 vs $0.46beat
- Thu, Apr 24$0.46 vs $0.46beat
Estimates and results for DOC via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
Project earnings forward and see what return today's price implies.
Seeded from DOC's reported EPS growth of -42.7% a year over 4 years. Historical EPS growth of -43% would project the company towards zero. Floored at -15% as a starting point.
- EPS in 5 years
- $0.05
- Implied price
- $0.82
- Return from $20.79
- -47.6% a year
To earn 15.0% a year on these assumptions you'd need to buy at $0.41 — -98.0% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 12 | 15 | 18 | 21 | 24 |
|---|---|---|---|---|---|
| -25.0% | -57.4% | -55.4% | -53.8% | -52.3% | -51.1% |
| -20.0% | -54.6% | -52.5% | -50.7% | -49.2% | -47.8% |
| -15.0% | -51.7% | -49.5% | -47.6% | -46.0% | -44.5% |
| -10.0% | -48.9% | -46.5% | -44.6% | -42.8% | -41.3% |
| -5.0% | -46.0% | -43.6% | -41.5% | -39.6% | -38.0% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Mentions (2)
- Newszacks.com·5d ago·Negative
Is the Options Market Predicting a Spike in Healthpeak Properties Stock? Investors need to pay close attention to DOC stock based on the movements in the options market lately.
View source ↗ - Newsmarketbeat.com·7d ago·Neutral
Healthpeak Properties Q2 Earnings Call Highlights Healthpeak Properties NYSE: DOC reported second-quarter adjusted funds from operations of $0.46 per share and raised its full-year adjusted FFO guidance by $0.02 to a range of $1.73 to $1.77 per share, citing improved same-store net operating income expectations in its lab and senior housing businesses.
View source ↗